FDA
approval
· 2012-04-12
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved Mylan Pharmaceuticals' supplemental application for Amnesteem (isotretinoin), a generic version of isotretinoin.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)